HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Stina Salomonsson Selected Research
Stina Salomonsson Research Topics
Disease
8
Congenital heart block
01/2022 - 05/2002
5
Atrioventricular Block
01/2022 - 01/2005
3
Heart Block
03/2012 - 04/2004
3
Inflammation (Inflammations)
05/2009 - 01/2003
2
Myositis (Idiopathic Inflammatory Myopathies)
02/2007 - 05/2006
1
Cardiomyopathies (Cardiomyopathy)
01/2022
1
Neonatal Systemic lupus erythematosus
01/2022
1
Genetic Predisposition to Disease (Genetic Predisposition)
01/2022
1
Multiple Myeloma
12/2021
1
Liver Neoplasms (Liver Cancer)
12/2021
1
Myocardial Infarction
01/2021
1
Atherosclerosis
01/2021
1
Psoriatic Arthritis
01/2019
1
Axial Spondyloarthritis
01/2019
1
Rheumatoid Arthritis
01/2019
1
Necrosis
01/2019
1
Rheumatic Diseases (Rheumatism)
01/2019
1
Osteoporosis
07/2016
1
Polymyositis
02/2007
1
Dermatomyositis (Dermatopolymyositis)
02/2007
1
Autoimmune Diseases (Autoimmune Disease)
01/2007
Drug/Important Bio-Agent (IBA)
11
Autoantibodies
IBA
01/2022 - 01/2003
5
Antibodies
IBA
03/2012 - 03/2004
4
Proteins (Proteins, Gene)
FDA Link
02/2007 - 03/2004
2
Interleukin-1 (Interleukin 1)
IBA
02/2007 - 05/2006
1
Auxilins
IBA
01/2022
1
Melphalan (Alkeran)
FDA Link
Generic
12/2021
1
Sorafenib (BAY 43-9006)
FDA Link
12/2021
1
Thalidomide (Thalomid)
FDA Link
12/2021
1
Prednisone (Sone)
FDA Link
Generic
12/2021
1
LDL Cholesterol
IBA
01/2021
1
oxidized low density lipoprotein
IBA
01/2021
1
golimumab
FDA Link
01/2019
1
Biological Products
IBA
01/2019
1
Diphosphonates (Bisphosphonates)
IBA
07/2016
1
Vitamin D
FDA Link
Generic
03/2012
1
Enzymes
IBA
05/2009
1
Ligands
IBA
02/2007
1
Interleukin-1 Receptors (Interleukin 1 Receptor)
IBA
02/2007
1
Cytokines
IBA
05/2006
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
05/2006
1
RNA (Ribonucleic Acid)
IBA
05/2006
1
Calcium
IBA
01/2005
1
Peptides (Polypeptides)
IBA
01/2005
1
Epitopes
IBA
01/2005
1
Amino Acids
FDA Link
03/2004
1
Antigens
IBA
05/2002
Therapy/Procedure
3
Therapeutics
01/2020 - 05/2006